R&D Update | New York

The key topics covered are:

•     Innate Pharma’s corporate strategy and positioning in the immuno-oncology space
•     Update on lirilumab clinical development
•     IPH2201 scientific rationale and clinical development plan
•     Financial update

The R&D Update is webcasted and available after the event at the following link: http://psav.rampard.com/20140410/